Yahoo India Web Search

Search results

    • FDA approves J&J’s multiple myeloma therapy

      FDA approves J&J’s multiple myeloma therapy

      Pharmaceutical Technology· 5 hours ago

      The most common adverse reactions observed were peripheral neuropathy, fatigue and oedema. Johnson & Johnson multiple myeloma disease area leader